Click for best price
CRISPR569 Market Size, Share 2023
The CRISPR-Cas technology is a?versatile genome editing tool?that has been used to improve agriculturally important crop traits, such as quality, disease resistance, and herbicide tolerance.
This report aims to provide a comprehensive presentation of the global market for CRISPR in 569, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR in 569. This report contains market size and forecasts of CRISPR in 569 in global, including the following market information:
Global CRISPR in 569 Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global CRISPR in 569 market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Crops Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of CRISPR in 569 include Arcadia Biosciences, Bayer AG, BASF SE, Beam Therapeutics Inc., Benson Hill Biosystems, Inc., Caribou Bioscience Inc., Calyxt, Inc., Cellectis SA and Cibus, Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CRISPR in 569 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR in 569 Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global CRISPR in 569 Market Segment Percentages, by Type, 2022 (%)
Crops
Livestock
Aquaculture
Global CRISPR in 569 Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global CRISPR in 569 Market Segment Percentages, by Application, 2022 (%)
Academic & Research Institutes
Biotech Companies
Global CRISPR in 569 Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global CRISPR in 569 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR in 569 revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRISPR in 569 revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arcadia Biosciences
Bayer AG
BASF SE
Beam Therapeutics Inc.
Benson Hill Biosystems, Inc.
Caribou Bioscience Inc.
Calyxt, Inc.
Cellectis SA
Cibus, Ltd.
CRISPR Therapeutics AG
DeciBio, LLC
E. I. du Pont de Nemours and Co.
Evogene Ltd.
GeneCopoeia inc.
Horizon Discovery Group PLC
Intellia Therapeutics, Inc.
J.R. Simplot Co.
Pairwise Plants
Synthetic Genomics Inc.
Tropic Biosciences UK LTD.
Yield10 Bioscience, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRISPR in 569, market overview.
Chapter 2: Global CRISPR in 569 market size in revenue.
Chapter 3: Detailed analysis of CRISPR in 569 company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRISPR in 569 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
CRISPR in 569 Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CRISPR in 569 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CRISPR in 569 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CRISPR in 569 Overall Market Size
2.1 Global CRISPR in 569 Market Size: 2022 VS 2030
2.2 Global CRISPR in 569 Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CRISPR in 569 Players in Global Market
3.2 Top Global CRISPR in 569 Companies Ranked by Revenue
3.3 Global CRISPR in 569 Revenue by Companies
3.4 Top 3 and Top 5 CRISPR in 569 Companies in Global Market, by Revenue in 2022
3.5 Global Companies CRISPR in 569 Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR in 569 Players in Global Market
3.6.1 List of Global Tier 1 CRISPR in 569 Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR in 569 Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CRISPR in 569 Market Size Markets, 2022 & 2030
4.1.2 Crops
4.1.3 Livestock
4.1.4 Aquaculture
4.2 By Type - Global CRISPR in 569 Revenue & Forecasts
4.2.1 By Type - Global CRISPR in 569 Revenue, 2018-2023
4.2.2 By Type - Global CRISPR in 569 Revenue, 2024-2030
4.2.3 By Type - Global CRISPR in 569 Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CRISPR in 569 Market Size, 2022 & 2030
5.1.2 Academic & Research Institutes
5.1.3 Biotech Companies
5.2 By Application - Global CRISPR in 569 Revenue & Forecasts
5.2.1 By Application - Global CRISPR in 569 Revenue, 2018-2023
5.2.2 By Application - Global CRISPR in 569 Revenue, 2024-2030
5.2.3 By Application - Global CRISPR in 569 Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global CRISPR in 569 Market Size, 2022 & 2030
6.2 By Region - Global CRISPR in 569 Revenue & Forecasts
6.2.1 By Region - Global CRISPR in 569 Revenue, 2018-2023
6.2.2 By Region - Global CRISPR in 569 Revenue, 2024-2030
6.2.3 By Region - Global CRISPR in 569 Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America CRISPR in 569 Revenue, 2018-2030
6.3.2 US CRISPR in 569 Market Size, 2018-2030
6.3.3 Canada CRISPR in 569 Market Size, 2018-2030
6.3.4 Mexico CRISPR in 569 Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe CRISPR in 569 Revenue, 2018-2030
6.4.2 Germany CRISPR in 569 Market Size, 2018-2030
6.4.3 France CRISPR in 569 Market Size, 2018-2030
6.4.4 U.K. CRISPR in 569 Market Size, 2018-2030
6.4.5 Italy CRISPR in 569 Market Size, 2018-2030
6.4.6 Russia CRISPR in 569 Market Size, 2018-2030
6.4.7 Nordic Countries CRISPR in 569 Market Size, 2018-2030
6.4.8 Benelux CRISPR in 569 Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia CRISPR in 569 Revenue, 2018-2030
6.5.2 China CRISPR in 569 Market Size, 2018-2030
6.5.3 Japan CRISPR in 569 Market Size, 2018-2030
6.5.4 South Korea CRISPR in 569 Market Size, 2018-2030
6.5.5 Southeast Asia CRISPR in 569 Market Size, 2018-2030
6.5.6 India CRISPR in 569 Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America CRISPR in 569 Revenue, 2018-2030
6.6.2 Brazil CRISPR in 569 Market Size, 2018-2030
6.6.3 Argentina CRISPR in 569 Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR in 569 Revenue, 2018-2030
6.7.2 Turkey CRISPR in 569 Market Size, 2018-2030
6.7.3 Israel CRISPR in 569 Market Size, 2018-2030
6.7.4 Saudi Arabia CRISPR in 569 Market Size, 2018-2030
6.7.5 UAE CRISPR in 569 Market Size, 2018-2030
7 CRISPR in 569 Companies Profiles
7.1 Arcadia Biosciences
7.1.1 Arcadia Biosciences Company Summary
7.1.2 Arcadia Biosciences Business Overview
7.1.3 Arcadia Biosciences CRISPR in 569 Major Product Offerings
7.1.4 Arcadia Biosciences CRISPR in 569 Revenue in Global Market (2018-2023)
7.1.5 Arcadia Biosciences Key News & Latest Developments
7.2 Bayer AG
7.2.1 Bayer AG Company Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG CRISPR in 569 Major Product Offerings
7.2.4 Bayer AG CRISPR in 569 Revenue in Global Market (2018-2023)
7.2.5 Bayer AG Key News & Latest Developments
7.3 BASF SE
7.3.1 BASF SE Company Summary
7.3.2 BASF SE Business Overview
7.3.3 BASF SE CRISPR in 569 Major Product Offerings
7.3.4 BASF SE CRISPR in 569 Revenue in Global Market (2018-2023)
7.3.5 BASF SE Key News & Latest Developments
7.4 Beam Therapeutics Inc.
7.4.1 Beam Therapeutics Inc. Company Summary
7.4.2 Beam Therapeutics Inc. Business Overview
7.4.3 Beam Therapeutics Inc. CRISPR in 569 Major Product Offerings
7.4.4 Beam Therapeutics Inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.4.5 Beam Therapeutics Inc. Key News & Latest Developments
7.5 Benson Hill Biosystems, Inc.
7.5.1 Benson Hill Biosystems, Inc. Company Summary
7.5.2 Benson Hill Biosystems, Inc. Business Overview
7.5.3 Benson Hill Biosystems, Inc. CRISPR in 569 Major Product Offerings
7.5.4 Benson Hill Biosystems, Inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.5.5 Benson Hill Biosystems, Inc. Key News & Latest Developments
7.6 Caribou Bioscience Inc.
7.6.1 Caribou Bioscience Inc. Company Summary
7.6.2 Caribou Bioscience Inc. Business Overview
7.6.3 Caribou Bioscience Inc. CRISPR in 569 Major Product Offerings
7.6.4 Caribou Bioscience Inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.6.5 Caribou Bioscience Inc. Key News & Latest Developments
7.7 Calyxt, Inc.
7.7.1 Calyxt, Inc. Company Summary
7.7.2 Calyxt, Inc. Business Overview
7.7.3 Calyxt, Inc. CRISPR in 569 Major Product Offerings
7.7.4 Calyxt, Inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.7.5 Calyxt, Inc. Key News & Latest Developments
7.8 Cellectis SA
7.8.1 Cellectis SA Company Summary
7.8.2 Cellectis SA Business Overview
7.8.3 Cellectis SA CRISPR in 569 Major Product Offerings
7.8.4 Cellectis SA CRISPR in 569 Revenue in Global Market (2018-2023)
7.8.5 Cellectis SA Key News & Latest Developments
7.9 Cibus, Ltd.
7.9.1 Cibus, Ltd. Company Summary
7.9.2 Cibus, Ltd. Business Overview
7.9.3 Cibus, Ltd. CRISPR in 569 Major Product Offerings
7.9.4 Cibus, Ltd. CRISPR in 569 Revenue in Global Market (2018-2023)
7.9.5 Cibus, Ltd. Key News & Latest Developments
7.10 CRISPR Therapeutics AG
7.10.1 CRISPR Therapeutics AG Company Summary
7.10.2 CRISPR Therapeutics AG Business Overview
7.10.3 CRISPR Therapeutics AG CRISPR in 569 Major Product Offerings
7.10.4 CRISPR Therapeutics AG CRISPR in 569 Revenue in Global Market (2018-2023)
7.10.5 CRISPR Therapeutics AG Key News & Latest Developments
7.11 DeciBio, LLC
7.11.1 DeciBio, LLC Company Summary
7.11.2 DeciBio, LLC Business Overview
7.11.3 DeciBio, LLC CRISPR in 569 Major Product Offerings
7.11.4 DeciBio, LLC CRISPR in 569 Revenue in Global Market (2018-2023)
7.11.5 DeciBio, LLC Key News & Latest Developments
7.12 E. I. du Pont de Nemours and Co.
7.12.1 E. I. du Pont de Nemours and Co. Company Summary
7.12.2 E. I. du Pont de Nemours and Co. Business Overview
7.12.3 E. I. du Pont de Nemours and Co. CRISPR in 569 Major Product Offerings
7.12.4 E. I. du Pont de Nemours and Co. CRISPR in 569 Revenue in Global Market (2018-2023)
7.12.5 E. I. du Pont de Nemours and Co. Key News & Latest Developments
7.13 Evogene Ltd.
7.13.1 Evogene Ltd. Company Summary
7.13.2 Evogene Ltd. Business Overview
7.13.3 Evogene Ltd. CRISPR in 569 Major Product Offerings
7.13.4 Evogene Ltd. CRISPR in 569 Revenue in Global Market (2018-2023)
7.13.5 Evogene Ltd. Key News & Latest Developments
7.14 GeneCopoeia inc.
7.14.1 GeneCopoeia inc. Company Summary
7.14.2 GeneCopoeia inc. Business Overview
7.14.3 GeneCopoeia inc. CRISPR in 569 Major Product Offerings
7.14.4 GeneCopoeia inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.14.5 GeneCopoeia inc. Key News & Latest Developments
7.15 Horizon Discovery Group PLC
7.15.1 Horizon Discovery Group PLC Company Summary
7.15.2 Horizon Discovery Group PLC Business Overview
7.15.3 Horizon Discovery Group PLC CRISPR in 569 Major Product Offerings
7.15.4 Horizon Discovery Group PLC CRISPR in 569 Revenue in Global Market (2018-2023)
7.15.5 Horizon Discovery Group PLC Key News & Latest Developments
7.16 Intellia Therapeutics, Inc.
7.16.1 Intellia Therapeutics, Inc. Company Summary
7.16.2 Intellia Therapeutics, Inc. Business Overview
7.16.3 Intellia Therapeutics, Inc. CRISPR in 569 Major Product Offerings
7.16.4 Intellia Therapeutics, Inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.16.5 Intellia Therapeutics, Inc. Key News & Latest Developments
7.17 J.R. Simplot Co.
7.17.1 J.R. Simplot Co. Company Summary
7.17.2 J.R. Simplot Co. Business Overview
7.17.3 J.R. Simplot Co. CRISPR in 569 Major Product Offerings
7.17.4 J.R. Simplot Co. CRISPR in 569 Revenue in Global Market (2018-2023)
7.17.5 J.R. Simplot Co. Key News & Latest Developments
7.18 Pairwise Plants
7.18.1 Pairwise Plants Company Summary
7.18.2 Pairwise Plants Business Overview
7.18.3 Pairwise Plants CRISPR in 569 Major Product Offerings
7.18.4 Pairwise Plants CRISPR in 569 Revenue in Global Market (2018-2023)
7.18.5 Pairwise Plants Key News & Latest Developments
7.19 Synthetic Genomics Inc.
7.19.1 Synthetic Genomics Inc. Company Summary
7.19.2 Synthetic Genomics Inc. Business Overview
7.19.3 Synthetic Genomics Inc. CRISPR in 569 Major Product Offerings
7.19.4 Synthetic Genomics Inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.19.5 Synthetic Genomics Inc. Key News & Latest Developments
7.20 Tropic Biosciences UK LTD.
7.20.1 Tropic Biosciences UK LTD. Company Summary
7.20.2 Tropic Biosciences UK LTD. Business Overview
7.20.3 Tropic Biosciences UK LTD. CRISPR in 569 Major Product Offerings
7.20.4 Tropic Biosciences UK LTD. CRISPR in 569 Revenue in Global Market (2018-2023)
7.20.5 Tropic Biosciences UK LTD. Key News & Latest Developments
7.21 Yield10 Bioscience, Inc.
7.21.1 Yield10 Bioscience, Inc. Company Summary
7.21.2 Yield10 Bioscience, Inc. Business Overview
7.21.3 Yield10 Bioscience, Inc. CRISPR in 569 Major Product Offerings
7.21.4 Yield10 Bioscience, Inc. CRISPR in 569 Revenue in Global Market (2018-2023)
7.21.5 Yield10 Bioscience, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CRISPR in 569 Market Opportunities & Trends in Global Market
Table 2. CRISPR in 569 Market Drivers in Global Market
Table 3. CRISPR in 569 Market Restraints in Global Market
Table 4. Key Players of CRISPR in 569 in Global Market
Table 5. Top CRISPR in 569 Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CRISPR in 569 Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CRISPR in 569 Revenue Share by Companies, 2018-2023
Table 8. Global Companies CRISPR in 569 Product Type
Table 9. List of Global Tier 1 CRISPR in 569 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRISPR in 569 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CRISPR in 569 Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - CRISPR in 569 Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CRISPR in 569 Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global CRISPR in 569 Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - CRISPR in 569 Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CRISPR in 569 Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global CRISPR in 569 Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global CRISPR in 569 Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CRISPR in 569 Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America CRISPR in 569 Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CRISPR in 569 Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe CRISPR in 569 Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CRISPR in 569 Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia CRISPR in 569 Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CRISPR in 569 Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America CRISPR in 569 Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CRISPR in 569 Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa CRISPR in 569 Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CRISPR in 569 Revenue, (US$, Mn), 2024-2030
Table 30. Arcadia Biosciences Company Summary
Table 31. Arcadia Biosciences CRISPR in 569 Product Offerings
Table 32. Arcadia Biosciences CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 33. Arcadia Biosciences Key News & Latest Developments
Table 34. Bayer AG Company Summary
Table 35. Bayer AG CRISPR in 569 Product Offerings
Table 36. Bayer AG CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer AG Key News & Latest Developments
Table 38. BASF SE Company Summary
Table 39. BASF SE CRISPR in 569 Product Offerings
Table 40. BASF SE CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 41. BASF SE Key News & Latest Developments
Table 42. Beam Therapeutics Inc. Company Summary
Table 43. Beam Therapeutics Inc. CRISPR in 569 Product Offerings
Table 44. Beam Therapeutics Inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 45. Beam Therapeutics Inc. Key News & Latest Developments
Table 46. Benson Hill Biosystems, Inc. Company Summary
Table 47. Benson Hill Biosystems, Inc. CRISPR in 569 Product Offerings
Table 48. Benson Hill Biosystems, Inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 49. Benson Hill Biosystems, Inc. Key News & Latest Developments
Table 50. Caribou Bioscience Inc. Company Summary
Table 51. Caribou Bioscience Inc. CRISPR in 569 Product Offerings
Table 52. Caribou Bioscience Inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 53. Caribou Bioscience Inc. Key News & Latest Developments
Table 54. Calyxt, Inc. Company Summary
Table 55. Calyxt, Inc. CRISPR in 569 Product Offerings
Table 56. Calyxt, Inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 57. Calyxt, Inc. Key News & Latest Developments
Table 58. Cellectis SA Company Summary
Table 59. Cellectis SA CRISPR in 569 Product Offerings
Table 60. Cellectis SA CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 61. Cellectis SA Key News & Latest Developments
Table 62. Cibus, Ltd. Company Summary
Table 63. Cibus, Ltd. CRISPR in 569 Product Offerings
Table 64. Cibus, Ltd. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 65. Cibus, Ltd. Key News & Latest Developments
Table 66. CRISPR Therapeutics AG Company Summary
Table 67. CRISPR Therapeutics AG CRISPR in 569 Product Offerings
Table 68. CRISPR Therapeutics AG CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 69. CRISPR Therapeutics AG Key News & Latest Developments
Table 70. DeciBio, LLC Company Summary
Table 71. DeciBio, LLC CRISPR in 569 Product Offerings
Table 72. DeciBio, LLC CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 73. DeciBio, LLC Key News & Latest Developments
Table 74. E. I. du Pont de Nemours and Co. Company Summary
Table 75. E. I. du Pont de Nemours and Co. CRISPR in 569 Product Offerings
Table 76. E. I. du Pont de Nemours and Co. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 77. E. I. du Pont de Nemours and Co. Key News & Latest Developments
Table 78. Evogene Ltd. Company Summary
Table 79. Evogene Ltd. CRISPR in 569 Product Offerings
Table 80. Evogene Ltd. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 81. Evogene Ltd. Key News & Latest Developments
Table 82. GeneCopoeia inc. Company Summary
Table 83. GeneCopoeia inc. CRISPR in 569 Product Offerings
Table 84. GeneCopoeia inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 85. GeneCopoeia inc. Key News & Latest Developments
Table 86. Horizon Discovery Group PLC Company Summary
Table 87. Horizon Discovery Group PLC CRISPR in 569 Product Offerings
Table 88. Horizon Discovery Group PLC CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 89. Horizon Discovery Group PLC Key News & Latest Developments
Table 90. Intellia Therapeutics, Inc. Company Summary
Table 91. Intellia Therapeutics, Inc. CRISPR in 569 Product Offerings
Table 92. Intellia Therapeutics, Inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 93. Intellia Therapeutics, Inc. Key News & Latest Developments
Table 94. J.R. Simplot Co. Company Summary
Table 95. J.R. Simplot Co. CRISPR in 569 Product Offerings
Table 96. J.R. Simplot Co. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 97. J.R. Simplot Co. Key News & Latest Developments
Table 98. Pairwise Plants Company Summary
Table 99. Pairwise Plants CRISPR in 569 Product Offerings
Table 100. Pairwise Plants CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 101. Pairwise Plants Key News & Latest Developments
Table 102. Synthetic Genomics Inc. Company Summary
Table 103. Synthetic Genomics Inc. CRISPR in 569 Product Offerings
Table 104. Synthetic Genomics Inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 105. Synthetic Genomics Inc. Key News & Latest Developments
Table 106. Tropic Biosciences UK LTD. Company Summary
Table 107. Tropic Biosciences UK LTD. CRISPR in 569 Product Offerings
Table 108. Tropic Biosciences UK LTD. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 109. Tropic Biosciences UK LTD. Key News & Latest Developments
Table 110. Yield10 Bioscience, Inc. Company Summary
Table 111. Yield10 Bioscience, Inc. CRISPR in 569 Product Offerings
Table 112. Yield10 Bioscience, Inc. CRISPR in 569 Revenue (US$, Mn) & (2018-2023)
Table 113. Yield10 Bioscience, Inc. Key News & Latest Developments
List of Figures
Figure 1. CRISPR in 569 Segment by Type in 2022
Figure 2. CRISPR in 569 Segment by Application in 2022
Figure 3. Global CRISPR in 569 Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CRISPR in 569 Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global CRISPR in 569 Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CRISPR in 569 Revenue in 2022
Figure 8. By Type - Global CRISPR in 569 Revenue Market Share, 2018-2030
Figure 9. By Application - Global CRISPR in 569 Revenue Market Share, 2018-2030
Figure 10. By Type - Global CRISPR in 569 Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global CRISPR in 569 Revenue Market Share, 2018-2030
Figure 12. By Application - Global CRISPR in 569 Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global CRISPR in 569 Revenue Market Share, 2018-2030
Figure 14. By Region - Global CRISPR in 569 Revenue Market Share, 2018-2030
Figure 15. By Country - North America CRISPR in 569 Revenue Market Share, 2018-2030
Figure 16. US CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 17. Canada CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe CRISPR in 569 Revenue Market Share, 2018-2030
Figure 20. Germany CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 21. France CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 23. Italy CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 24. Russia CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia CRISPR in 569 Revenue Market Share, 2018-2030
Figure 28. China CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 29. Japan CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 32. India CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America CRISPR in 569 Revenue Market Share, 2018-2030
Figure 34. Brazil CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa CRISPR in 569 Revenue Market Share, 2018-2030
Figure 37. Turkey CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 38. Israel CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 40. UAE CRISPR in 569 Revenue, (US$, Mn), 2018-2030
Figure 41. Arcadia Biosciences CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer AG CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BASF SE CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Beam Therapeutics Inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Benson Hill Biosystems, Inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Caribou Bioscience Inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Calyxt, Inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Cellectis SA CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cibus, Ltd. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CRISPR Therapeutics AG CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. DeciBio, LLC CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. E. I. du Pont de Nemours and Co. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Evogene Ltd. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. GeneCopoeia inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Horizon Discovery Group PLC CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Intellia Therapeutics, Inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. J.R. Simplot Co. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Pairwise Plants CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Synthetic Genomics Inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Tropic Biosciences UK LTD. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Yield10 Bioscience, Inc. CRISPR in 569 Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
